ShangPharma Corp. (SHP) Misses Q1 EPS by 2c; Reaffirms Outlook
Get Alerts SHP Hot Sheet
Join SI Premium – FREE
ShangPharma Corp. (NYSE: SHP) reported Q1 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $30.8 million versus the consensus estimate of $29.8 million.
ShangPharma Corp. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
ShangPharma Corp. reaffirmed FY2012 guidance.
For earnings history and earnings-related data on ShangPharma Corp. (SHP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
- QNB Corp. (QNBC) Reports Q1 EPS of $0.71
- Greene County Bancorp, Inc. (GCBC) Reports Q3 EPS of $0.34
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!